These results collectively suggest that circMETTL3 plays an important tumor suppressor role in TNBC progression via miR-34c-3p/METTL3 signaling and may be a potential prognostic biomarker and therapeutic target for TNBC. The gene discussed is METTL3; the disease is neoplasm.